GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Level Bio AB (XSAT:LEVBIO) » Definitions » Total Assets

Level Bio AB (XSAT:LEVBIO) Total Assets : kr15.74 Mil (As of Mar. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Level Bio AB Total Assets?

Level Bio AB's Total Assets for the quarter that ended in Mar. 2024 was kr15.74 Mil.

Warning Sign:

If a company builds assets at 19.4% a year, faster than its revenue growth rate of 8.7% over the past 5 years, it means that the company may be getting less efficient.

During the past 12 months, Level Bio AB's average Total Assets Growth Rate was -37.80% per year. During the past 3 years, the average Total Assets Growth Rate was 22.20% per year. During the past 5 years, the average Total Assets Growth Rate was 19.40% per year. During the past 10 years, the average Total Assets Growth Rate was 3.10% per year.

During the past 13 years, Level Bio AB's highest 3-Year average Total Assets Growth Rate was 39.20%. The lowest was -16.00%. And the median was -5.20%.

Total Assets is connected with ROA %. Level Bio AB's annualized ROA % for the quarter that ended in Mar. 2024 was -56.39%. Total Assets is also linked to Revenue through Asset Turnover. Level Bio AB's Asset Turnover for the quarter that ended in Mar. 2024 was 0.32.


Level Bio AB Total Assets Historical Data

The historical data trend for Level Bio AB's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Level Bio AB Total Assets Chart

Level Bio AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.80 9.90 32.06 28.80 19.09

Level Bio AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.99 23.24 21.50 19.09 15.74

Level Bio AB Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Level Bio AB's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (A: Dec. 2023 )+Total Liabilities (A: Dec. 2023 )
=10.415+8.678
=19.09

Level Bio AB's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets=Total Equity (Q: Mar. 2024 )+Total Liabilities (Q: Mar. 2024 )
=7.96+7.777
=15.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Level Bio AB  (XSAT:LEVBIO) Total Assets Explanation

Total Assets is connected with ROA %.

Level Bio AB's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %=Net Income (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=-9.82/( (19.093+15.737)/ 2 )
=-9.82/17.415
=-56.39 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Level Bio AB's Asset Turnover for the quarter that ended in Mar. 2024 is

Asset Turnover
=Revenue (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=5.504/( (19.093+15.737)/ 2 )
=5.504/17.415
=0.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Level Bio AB Total Assets Related Terms

Thank you for viewing the detailed overview of Level Bio AB's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Level Bio AB (XSAT:LEVBIO) Business Description

Traded in Other Exchanges
Address
Vastra Finnbodavagen 4B, Nacka, Stockholm, SWE, 131 30
AlphaHelix Molecular Diagnostics AB develops, manufactures, and markets products for DNA-identification and quantitation in molecular diagnostics and life science research. Its product inlcude Rob, BugScreener MRSA, and aAmp. The company applications inlcude Diagnostics, PCR and Liquid handling.

Level Bio AB (XSAT:LEVBIO) Headlines

No Headlines